1

Baricitinib Phosphate (1187595-84-1) Baricitinib is a selective JAK1 and JAK2 inhibitor that has shown promising results as a treatment for rheumatoid arthritis and other inflammatory conditions. Product Name Baricitinib Phosphate CAS No. 1187595-84-1 Assay 98% Specification CP, EP, In-house, as required Molecular Formula C16 H20 N7 O6 PS Molecular Weight 469.41 Shelf Life 2 Years Package 25kg/drum

Ozanimod (1306760-87-1) Ozanimod is a selective agonist that binds to S1P1 and S1P5 receptors. Preclinical studies in rodent models have demonstrated its efficacy against autoimmune diseases. Product Specifications Product Name: Ozanimod CAS No.: 1306760-87-1 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C23 H24 N4 O3 Molecular Weight: 404.46 Shelf Life: 2 Years Package: 25kg/drum Product Documentation

Ibrutinib (936563-96-1) Ibrutinib is a non-receptor Bruton's tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenstrm's Macroglobulinemia (WM). Product Name: Ibrutinib CAS No.: 936563-96-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C25 H24 N6 O2 Molecular Weight: 440.5 Shelf Life: 2 Years Package: 25kg/drum

Methyl 3-formyl-2-nitrobenzoate (CAS 138229-59-1) Methyl 3-formyl-2-nitrobenzoate is a key intermediate in the synthesis of Niraparib, an important pharmaceutical compound. Product Specifications Product Name Methyl 3-formyl-2-nitrobenzoate CAS Number 138229-59-1 Assay 98% End Use Niraparib Tosylate Monohydrate Molecular Formula CHNO Molecular Weight 209.16 g/mol Shelf Life 2 Years Package 25kg/drum Product Documentation

5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid (131052-68-1) 5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid is used as an intermediate in the synthesis of Raltitrexed. Product Specifications Product Name: 5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid CAS No.: 131052-68-1 Assay: 98% End Use: Raltitrexed Molecular Formula: C11 H15 NO4 S Molecular Weight: 257.3 Shelf Life: 2 Years Package: 25kg/drum Product

Vericiguat (1350653-20-1) Vericiguat targets cyclic guanosine monophosphate and is used in the treatment of heart failure. Product Specifications Product Name: Vericiguat CAS No.: 1350653-20-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C19 H16 F2 N8 O2 Molecular Weight: 426.38 Shelf Life: 2 Years Package: 25kg/drum Product Images

1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one (CAS: 18048-64-1) 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one is a key pharmaceutical intermediate used in the synthesis of Eltrombopag. Product Specifications Product Name: 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one CAS No.: 18048-64-1 Assay: 98% End Use: Eltrombopag olamine Molecular Formula: C12 H14 N2 O Molecular Weight: 202.25 Shelf Life: 2 Years Package: 25kg/drum Product Images

Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate (1206124-13-1) Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate is a key pharmaceutical intermediate used in the synthesis of Etrasimod. Product Specifications Product Name: Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS No.: 1206124-13-1 Assay: 98% End Use: Etrasimod Intermediate Molecular Formula: C15 H17 NO3 Molecular Weight: 259.3 Shelf Life: 2 Years Package:

(S)-1-Boc-3-hydroxypiperidine (CAS 143900-44-1) (S)-1-Boc-3-hydroxypiperidine is a key chiral intermediate specifically used in the synthesis of Ibrutinib, an important pharmaceutical compound. This high-purity chemical intermediate is essential for pharmaceutical manufacturing processes. Product Specifications Product Name (S)-1-Boc-3-hydroxypiperidine CAS Number 143900-44-1 Assay 98% End Use Ibrutinib Intermediate Molecular Formula C10 H19 NO3 Molecular Weight 201.26 g/mol